Pay in 4 interest-free payments of $46.86 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
CMPD101 exhibits selectivity for GRK2/3 over GRK1/5 and reduces DAMGO-induced desensitization and internalization of μ-opioid receptors
It aids in the prevention of acute and delayed nausea and vomiting associated with chemotherapy treatment
It inhibits primary tumor growth in multiple xenograft models
Systematic exploration of the structural features of yatakemycin impacting DNA alkylation and biological activity
PD-089828 camsule.2Na CMPD101 exhibits selectivity for GRK2/3PD 089828 is an ATP competitive inhibitor of FGFR 1, PDGFR and EGFR (IC50s=0. 15, 1. 76, and 5. 47 M, respectively) and a noncompetitive inhibitor of c Src tyrosine kinase (IC50=0. 18 M). PD 089828 also inhibits MAPK with an IC50 of 7. 1 M. PD 089828 inhibits PDGF , EGF and bFGF mediated tyrosine kinase receptor autophosphorylation in vitro. PD 089828 has a long lasting cellular activity. Product information CAS Number: 179343 17 0 Molecular Weight: